Work

P-473 Phase II trial of temozolomide and innotecan as second-linetreatment for advance non-small cell lung cancer

Year: 2005

Type: conference-abstract

Source: Lung Cancer

DOI: 10.1016/s0169-5002(05)80966-3

Authors: N. Choong, A. Mauer, P. Hoffman, P. Ma, E. Cohen, C. Rudin, M. Kozloff, D. Sciortino, L. Szeto, E. Vokes

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1998645421

Cites:

Cited by:

Related to: 10